PTCT icon

PTC Therapeutics

114 hedge funds and large institutions have $615M invested in PTC Therapeutics in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 38 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

0% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 38

1% less funds holding

Funds holding: 115114 (-1)

9.91% less ownership

Funds ownership: 91.23%81.32% (-9.9%)

Holders
114
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$19.1M
Puts
$9.92M
Net Calls
Net Calls Change

Top Buyers

1 +$72.3M
2 +$36.6M
3 +$13.6M
4
Morgan Stanley
Morgan Stanley
New York
+$9.19M
5
GPP
Great Point Partners
Connecticut
+$7.91M

Top Sellers

1 -$22.9M
2 -$13.7M
3 -$9.65M
4
Millennium Management
Millennium Management
New York
-$7.36M
5
BB
BB Biotech
Switzerland
-$6.72M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$4.17M
27
$3.67M
28
$3.33M
29
$2.97M
30
$2.96M
31
$2.83M
32
$2.76M
33
$2.2M
34
$2.15M
35
$2.08M
36
$1.83M
37
$1.79M
38
$1.67M
39
$1.67M
40
$1.64M
41
$1.15M
42
$1.14M
43
$1.12M
44
$1.11M
45
$1.08M
46
$1.04M
47
$985K
48
$928K
49
$928K
50
$927K